Keeps Biopharma Inc. (KOSDAQ:256940)

South Korea · Delayed Price · Currency is KRW

5,610.00

+290.00 (5.45%)

At close: Jul 31, 2026

Keeps Biopharma Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	188,936	170,147	127,583	92,133	14,617	4,261
Revenue Growth	38.39%	33.36%	38.48%	530.30%	243.09%	-72.00%
Gross Profit	38,612	37,576	17,240	12,798	1,044	-788.97
Operating Income	821.73	1,575	6,225	3,060	-8,915	-12,307
Net Income	-2,382	-9,785	1,113	3,930	-11,375	-15,317
Earnings Per Share	-119.58	-498.81	59.00	209.00	-607.03	-884.60
EPS Growth	-	-	-71.77%	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	31,060	26,571	22,988	10,910	25,203	40,889
Total Debt	94,779	92,593	55,737	48,304	28,820	27,603
Net Cash (Debt)	-63,720	-66,022	-32,749	-37,395	-3,617	13,286
Net Cash Growth	-	-	-	-	-	21.17%
Net Cash Per Share	-3198.88	-3365.52	-1735.34	-1987.66	-193.02	767.26

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-10,028	-14,921	4,808	-57.13	-866.26	-8,380
Capital Expenditures	-32,660	-31,933	-6,596	-990.97	-95.85	-90.75
Free Cash Flow	-42,688	-46,854	-1,787	-1,048	-962.12	-8,471
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	20.44%	22.09%	13.51%	13.89%	7.14%	-18.52%
Operating Margin	0.43%	0.92%	4.88%	3.32%	-60.99%	-288.86%
Pretax Margin	-2.42%	-6.88%	2.64%	5.83%	-94.94%	-406.17%
Profit Margin	-1.26%	-5.75%	0.87%	4.27%	-77.82%	-359.52%
FCF Margin	-22.59%	-27.54%	-1.40%	-1.14%	-6.58%	-198.82%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	87.73	30.53	-	-
Forward PE	-	16.78	3.21	3.21	3.21	3.21
PS Ratio	0.60	1.23	0.77	1.30	8.75	55.30